3000 patients join hunt for lung cancer biomarkers
NCT ID NCT06054854
First seen Mar 20, 2026 · Last updated Jun 22, 2026 · Updated 14 times
Summary
This study is building a large collection of blood, urine, saliva, and other samples from 3000 people with lung nodules or lung cancer. Researchers hope to find biological markers that can help diagnose lung cancer earlier, predict how the disease will progress, and guide treatment choices. Participants provide extra samples during routine care, with no direct treatment involved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Larrey Hospital
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better diagnose lung cancer early and choose more effective treatments for each patient.
What could go wrong
This is an observational biobank study, not a treatment trial. It may take years to find useful biomarkers, and not all discoveries will lead to practical tests.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.